Meet the inlaws: Embryonic stem cell derivatives meet the immune system
@@ Since the derivation of embryonic stem (ES) cell lines from human blasto-cysts in 1998 ”1”, ES cells have emerged as a potential source of cells and tissues that could be used for cell replacement therapy of incurable degenerative diseases. This is due to their remarkable pluripotency, which enables them to differentiate into any adult cell type of the three embryonal germ layers.
immune system、replacement therapy、potential source、cells、type of、three、human
19
Q2(细胞生物学)
the Department of Veteranss Affairs,Veterans Health Adminis-tration,Office of Research and Development;the NIH/NHLBIRO1 HL073015;NIAID,USAF30HL096343-01
2009-05-15(万方平台首次上网日期,不代表论文的发表时间)
共2页
397-398